Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-10, Vol.27, p.vi196-vi196 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | vi196 |
|---|---|
| container_issue | |
| container_start_page | vi196 |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Diakos, C.I. Tu, D. Gebski, V. Yip, S. Wilson, K. Karapetis, C.S. O'Callaghan, C.J. Shapiro, J. Tebbutt, N. Jonker, D.J. Siu, L.L. Wong, R. Doyle, C. Strickland, A.H. Price, T.J. Simes, J. Clarke, S. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw370.136 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw370_136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419442178</els_id><sourcerecordid>S0923753419442178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3256-af36b65f538b383007173b13a7c2056d7cc60de3963e1cc9c92fdd30760f66f83</originalsourceid><addsrcrecordid>eNp9kM1u2zAMx4VhBZa1fYDdeEwObiWrlmPsMARGtwYIGiBYz4ZC0Ys2WzIktUWeay84Zem5F5Ig-efHj7Evgt8I3shb7Zx3eDuaV1nnlFQf2ExUqimW_E58ZDPelLKoK3n3iX2O8TfnXDVlM2N_1xHSgcBQsC9kwNFzCn462AGSh-E4TgePx0QQdLIe5uZxs1uAdmCdoYmycQmm4H85H5NFGHX4QyFXYcqCXIzwatMBRko6Jn1qQT_4QJj0AKgd5u752O7axTdYOT0co43g-_9HtdsbUedl5hSVHGJ6NpbiFbvo9RDp-s1fsqfv9z_bh2Kz_bFuV5sCZVmpQvdS7VXVV3K5l0vJeS1quRdS11jySpkaUXFDslGSBGKDTdkbI3mteK9Uv5SXTJznYvAxBuq7Kdj84LETvDtR787UuzP1LlPPmq9nDeXDXiyFLmLGgGTs6efOePuO-h9QrY6r</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Diakos, C.I. ; Tu, D. ; Gebski, V. ; Yip, S. ; Wilson, K. ; Karapetis, C.S. ; O'Callaghan, C.J. ; Shapiro, J. ; Tebbutt, N. ; Jonker, D.J. ; Siu, L.L. ; Wong, R. ; Doyle, C. ; Strickland, A.H. ; Price, T.J. ; Simes, J. ; Clarke, S.</creator><creatorcontrib>Diakos, C.I. ; Tu, D. ; Gebski, V. ; Yip, S. ; Wilson, K. ; Karapetis, C.S. ; O'Callaghan, C.J. ; Shapiro, J. ; Tebbutt, N. ; Jonker, D.J. ; Siu, L.L. ; Wong, R. ; Doyle, C. ; Strickland, A.H. ; Price, T.J. ; Simes, J. ; Clarke, S.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw370.136</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi196-vi196</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3256-af36b65f538b383007173b13a7c2056d7cc60de3963e1cc9c92fdd30760f66f83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Diakos, C.I.</creatorcontrib><creatorcontrib>Tu, D.</creatorcontrib><creatorcontrib>Gebski, V.</creatorcontrib><creatorcontrib>Yip, S.</creatorcontrib><creatorcontrib>Wilson, K.</creatorcontrib><creatorcontrib>Karapetis, C.S.</creatorcontrib><creatorcontrib>O'Callaghan, C.J.</creatorcontrib><creatorcontrib>Shapiro, J.</creatorcontrib><creatorcontrib>Tebbutt, N.</creatorcontrib><creatorcontrib>Jonker, D.J.</creatorcontrib><creatorcontrib>Siu, L.L.</creatorcontrib><creatorcontrib>Wong, R.</creatorcontrib><creatorcontrib>Doyle, C.</creatorcontrib><creatorcontrib>Strickland, A.H.</creatorcontrib><creatorcontrib>Price, T.J.</creatorcontrib><creatorcontrib>Simes, J.</creatorcontrib><creatorcontrib>Clarke, S.</creatorcontrib><title>Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u2zAMx4VhBZa1fYDdeEwObiWrlmPsMARGtwYIGiBYz4ZC0Ys2WzIktUWeay84Zem5F5Ig-efHj7Evgt8I3shb7Zx3eDuaV1nnlFQf2ExUqimW_E58ZDPelLKoK3n3iX2O8TfnXDVlM2N_1xHSgcBQsC9kwNFzCn462AGSh-E4TgePx0QQdLIe5uZxs1uAdmCdoYmycQmm4H85H5NFGHX4QyFXYcqCXIzwatMBRko6Jn1qQT_4QJj0AKgd5u752O7axTdYOT0co43g-_9HtdsbUedl5hSVHGJ6NpbiFbvo9RDp-s1fsqfv9z_bh2Kz_bFuV5sCZVmpQvdS7VXVV3K5l0vJeS1quRdS11jySpkaUXFDslGSBGKDTdkbI3mteK9Uv5SXTJznYvAxBuq7Kdj84LETvDtR787UuzP1LlPPmq9nDeXDXiyFLmLGgGTs6efOePuO-h9QrY6r</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Diakos, C.I.</creator><creator>Tu, D.</creator><creator>Gebski, V.</creator><creator>Yip, S.</creator><creator>Wilson, K.</creator><creator>Karapetis, C.S.</creator><creator>O'Callaghan, C.J.</creator><creator>Shapiro, J.</creator><creator>Tebbutt, N.</creator><creator>Jonker, D.J.</creator><creator>Siu, L.L.</creator><creator>Wong, R.</creator><creator>Doyle, C.</creator><creator>Strickland, A.H.</creator><creator>Price, T.J.</creator><creator>Simes, J.</creator><creator>Clarke, S.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies</title><author>Diakos, C.I. ; Tu, D. ; Gebski, V. ; Yip, S. ; Wilson, K. ; Karapetis, C.S. ; O'Callaghan, C.J. ; Shapiro, J. ; Tebbutt, N. ; Jonker, D.J. ; Siu, L.L. ; Wong, R. ; Doyle, C. ; Strickland, A.H. ; Price, T.J. ; Simes, J. ; Clarke, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3256-af36b65f538b383007173b13a7c2056d7cc60de3963e1cc9c92fdd30760f66f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diakos, C.I.</creatorcontrib><creatorcontrib>Tu, D.</creatorcontrib><creatorcontrib>Gebski, V.</creatorcontrib><creatorcontrib>Yip, S.</creatorcontrib><creatorcontrib>Wilson, K.</creatorcontrib><creatorcontrib>Karapetis, C.S.</creatorcontrib><creatorcontrib>O'Callaghan, C.J.</creatorcontrib><creatorcontrib>Shapiro, J.</creatorcontrib><creatorcontrib>Tebbutt, N.</creatorcontrib><creatorcontrib>Jonker, D.J.</creatorcontrib><creatorcontrib>Siu, L.L.</creatorcontrib><creatorcontrib>Wong, R.</creatorcontrib><creatorcontrib>Doyle, C.</creatorcontrib><creatorcontrib>Strickland, A.H.</creatorcontrib><creatorcontrib>Price, T.J.</creatorcontrib><creatorcontrib>Simes, J.</creatorcontrib><creatorcontrib>Clarke, S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diakos, C.I.</au><au>Tu, D.</au><au>Gebski, V.</au><au>Yip, S.</au><au>Wilson, K.</au><au>Karapetis, C.S.</au><au>O'Callaghan, C.J.</au><au>Shapiro, J.</au><au>Tebbutt, N.</au><au>Jonker, D.J.</au><au>Siu, L.L.</au><au>Wong, R.</au><au>Doyle, C.</au><au>Strickland, A.H.</au><au>Price, T.J.</au><au>Simes, J.</au><au>Clarke, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi196</spage><epage>vi196</epage><pages>vi196-vi196</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw370.136</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-10, Vol.27, p.vi196-vi196 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw370_136 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T00%3A45%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20derived%20neutrophil%20to%20lymphocyte%20ratio%20(dNLR)%20an%20independent%20prognostic%20marker%20in%20patients%20with%20metastatic%20colorectal%20cancer%20(mCRC)?%20Analysis%20of%20the%20CO.17%20and%20CO.20%20studies&rft.jtitle=Annals%20of%20oncology&rft.au=Diakos,%20C.I.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi196&rft.epage=vi196&rft.pages=vi196-vi196&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw370.136&rft_dat=%3Celsevier_cross%3ES0923753419442178%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419442178&rfr_iscdi=true |